Research and development employees are the engine behind a company’s ability to create new products, improve existing ones, and stay ahead of competitors. They translate scientific knowledge and technical expertise into the innovations that drive revenue growth, protect market position through patents, and increasingly determine a company’s long-term stock performance. Without them, a business is essentially coasting on what already exists.
They Drive the Products That Generate Future Revenue
R&D employees are directly responsible for turning ideas into marketable products and services. This isn’t a minor line item on a company budget. U.S. businesses collectively performed $498.2 billion worth of R&D in 2019, and that figure has only grown since. Across all industries, companies spend an average of 4.4% of their sales on R&D activities, but in research-intensive sectors like biopharmaceuticals, that figure climbs dramatically. Global biopharma R&D intensity averages 27%, and U.S. biopharma companies reinvest roughly 34% of their revenue back into R&D.
To put that in perspective, biopharmaceutical companies spend far more on R&D than on sales and marketing. For every dollar U.S. biopharma companies spend on marketing, they invest $5.70 in R&D. That ratio signals how central R&D staff are to these companies’ business models. The people doing the research aren’t a support function. They are the core product team.
They Create and Protect Intellectual Property
Patents are one of the most tangible outputs of R&D work, and they serve as legal barriers that prevent competitors from copying a company’s innovations. Census Bureau research linking patent records to employment data reveals some interesting dynamics about who generates the most valuable intellectual property. Inventors at younger, smaller firms produce slightly fewer patents than those at large established companies, but their patents tend to be significantly more impactful, receiving 35% more citations from other inventors. Meanwhile, R&D employees at older firms earn about 12% more in salary but generate roughly 4% fewer patents of lower overall quality.
This matters for hiring strategy. The value of R&D employees isn’t just in volume of output. It’s in the originality and influence of what they create. Companies that want breakthrough innovations rather than incremental improvements need to think carefully about how they structure their R&D teams and what kind of creative latitude they offer.
They Catch Costly Problems Before Launch
One of the less visible but critical roles R&D employees play is identifying technical risks early, before a company commits millions to a flawed product direction. Technical feasibility work, which is core R&D activity, evaluates how difficult a proposed technology is to implement, whether it will integrate with existing systems, and whether it can scale up to meet real-world demand.
This early-warning function saves enormous amounts of money. In pharmaceutical development, for example, the most common reasons drugs fail in late-stage clinical trials are lack of efficacy (56% of failures) and safety issues (28%). These are problems that R&D teams work to identify as early as possible, because catching them in preclinical stages costs a fraction of what it costs to discover them in Phase III trials. The same principle applies across industries: R&D employees who run proof-of-concept tests, stress-test prototypes, and evaluate technical limitations prevent companies from pouring resources into products that will never work.
Companies that lack deep R&D expertise pay the price. Research on pharmaceutical firms shows that smaller organizations with less R&D know-how have lower success rates from Phase I trials through regulatory submission compared to larger companies with experienced R&D teams.
They Increase Long-Term Company Value
R&D spending is one of the strongest predictors of a company’s future stock performance. Multiple studies across both developed and emerging markets have found that companies with higher R&D intensity (R&D spending as a share of revenue) tend to deliver higher stock returns over time. This relationship holds in the U.S., Europe, India, China, Turkey, and Pakistan, suggesting it’s a fundamental market dynamic rather than a regional quirk.
The key finding is that R&D intensity, not just the raw dollar amount spent on R&D, is what matters. A company spending 15% of revenue on R&D signals to investors that it’s building future capabilities, and the market rewards that. More recent R&D activity carries more weight in how investors value a company, which means consistent, ongoing investment in R&D talent is more valuable than sporadic bursts of spending. The market treats a company’s intangible assets, including the knowledge and capabilities housed in its R&D workforce, as seriously as its physical assets when determining value.
They Power Sustainability and Regulatory Compliance
As environmental regulations tighten globally, R&D employees have become essential to a company’s ability to meet carbon reduction targets and develop green technologies. R&D investment gives firms the technological knowledge and resources to optimize natural resource use and reduce emissions. Companies that prioritize R&D can anticipate regulatory changes and consumer expectations rather than scrambling to comply after the fact.
This proactive positioning creates a competitive advantage. Firms that invest in R&D for sustainable innovation can meet or exceed compliance requirements before they become mandatory, which strengthens their market legitimacy and avoids the costs of last-minute adjustments. R&D teams also help companies navigate the uncertainty inherent in evolving environmental regulations by developing flexible solutions that can adapt as standards change.
They Shape How Companies Compete
The structure and quality of a company’s R&D workforce increasingly determines its competitive position. About 1.8 million people in the U.S. work in R&D roles across businesses with 10 or more employees, including researchers, managers, technicians, and support staff. That talent pool is not evenly distributed, and companies that attract and retain the best R&D employees gain advantages that are difficult for competitors to replicate.
The pharmaceutical industry offers a clear example of how R&D talent reshapes entire business models. About 73% of major research-based pharma companies have restructured their R&D operations in recent years, breaking large departments into smaller, more agile units that mimic biotech startups. They’re also broadening their talent strategies by hiring people who can work across cultures, think in open-innovation frameworks, and collaborate with external partners. The goal is to make R&D teams not just technically skilled but strategically versatile.
This trend extends beyond pharma. In any industry where products have a shelf life, where technology evolves, or where customer expectations shift, R&D employees are the people who keep a company from becoming obsolete. They don’t just build what’s next. They define what’s possible.